NMPA: Seven Recalls Announced in January 2020

Emergency Approvals Surged under Coronavirus Outbreak
February 7, 2020
NMPA Guideline on Coronavirus Nucleic Acid Detection Reagent Published Today
February 12, 2020

NMPA: Seven Recalls Announced in January 2020

NMPA announced seven recalls in January 2020:

  1. Johnson & Johnson: Contact lens
  2. Philips Medical Systems: Medical angiography X-ray system
  3. Medtronic: Drug infusion system
  4. GE: Anesthesia system
  5. Biomet Orthopedics: Hip modular system
  6. St. Jude Medical: Hemostasis introducer
  7. Synthes: Locking screws

For causes and model numbers of the recalls in January, please email info@ChinaMedDevice.com.

For Decree 29 Measures for the Administration of Medical Device Recall, please email us also. We charge nominal fees for the translation.

For our webinar on China PMS, please click HERE.


To keep up to date on NMPA (CFDA) changes, please opt in our monthly newsletter https://ChinaMedDevice.com/cmd-blogs/

About ChinaMed Device, LLC 

ChinaMed Device, LLC (www.ChinaMedDevice.com) provides regulatory and commercialization turnkey solutions for medical device, IVD, CDx and combination products in China. As a qualified NMPA (CFDA) legal representative with offices in Boston and Beijing, we can represent manufacturers for the complete product life cycle without their need to create a local entity in China. Our NMPA (CFDA) regulatory services include strategy, registration, local type testing, product technical requirement (PTR), clinical evaluation report (CER), clinical trial, GMP and post-market surveillance (AE, recall, inspection, etc.). Our commercialization services include market research, reimbursement, partnership strategy and distribution qualification.